The Cancer Survivors Network (CSN) is a peer support community for cancer patients, survivors, caregivers, families, and friends! CSN is a safe place to connect with others who share your interests and experiences.

IDH1 Development

dmercer1
dmercer1 CSN Member Posts: 16
in Brain Cancer #1

Anyone else see this? Pretty exciting.

http://www.webwire.com/ViewPressRel.asp?aId=180575#.UkMGNbx5iqQ

Like Care

Comments

  • I_Promise
    I_Promise CSN Member Posts: 218 Member
    #2
    Thank you

    for sharing this info. I had not seen it. What is interesting is that the drug used 5-azacytidine is already an FDA approved drug for other cancers. So I guess an oncologist could always prescribe it off label if she/he wanted to... Of course you need to carry the mutation IDH1 mutation (present in 70-80% of low grade gliomas) to use this new drug. I hope they fast forward a clinical trial.

    J.

     

    Like Care

Discussion Boards